Delivery Order SPE2DB22D3004-SPE2DB25FPS90
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,699.40 firm-fixed-price delivery order is for 4,566,716,754 units of Alfuzosin HCl ER 10 mg tablets, with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,788.12 firm fixed-price delivery order is for the supply of 4,565,550,860 units of the medication Alfuzosin HCL ER 10 mg tablets, with an ultimate completion date of August 23, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,092.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of 4566317084 - Alfuzosin HCL ER 10 mg Tablets, in quantities of 120 per bottle. This...
This federal contract award, with ID SPE2DB24D1021|SPE2DB24FERQX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,389.86, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.29 firm fixed price delivery order is for 90 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award, with the ID SPE2DB22D3019|SPE2DB24FK3UU, is for the delivery of 4,565,611,278 units of the pharmaceutical product Alfuzosin HCl ER 10 mg tablets. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical and medical products to the federal government. The contract has a firm fixed price of $12,111.00 and an ultimate completion date of August 29, 2024. The contracting agency is the Defense Logistics Agency (DLA), which is a defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,615.41 firm fixed-price delivery order is for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has an ultimate completion date of September 12, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,878.00, is a Firm Fixed Price Delivery Order for the supply of Alfuzosin HCL ER 10 mg tablets. The award does not utilize any set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,398.26, is for the delivery of Alfuzosin HCL ER 10 mg tablets over a period ending on October 20, 2023. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...